These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22375802)

  • 1. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling.
    Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ
    J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Software for quantitative proteomic analysis using stable isotope labeling and data independent acquisition.
    Huang X; Liu M; Nold MJ; Tian C; Fu K; Zheng J; Geromanos SJ; Ding SJ
    Anal Chem; 2011 Sep; 83(18):6971-9. PubMed ID: 21834580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics using 16O/18O labeling and linear ion trap mass spectrometry.
    López-Ferrer D; Ramos-Fernández A; Martínez-Bartolomé S; García-Ruiz P; Vázquez J
    Proteomics; 2006 Apr; 6 Suppl 1():S4-11. PubMed ID: 16534745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
    Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
    Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic 18O-labeling strategies for quantitative proteomics.
    Miyagi M; Rao KC
    Mass Spectrom Rev; 2007; 26(1):121-36. PubMed ID: 17086517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic labeling with 18O for comparative proteomics studies: preparation of 18O-labeled peptides and the 18O/16O peptide mixture.
    Fenselau C; Yao X
    Methods Mol Biol; 2007; 359():135-42. PubMed ID: 17484115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining pluripotent stem cells through quantitative proteomic analysis.
    Reiland S; Salekdeh GH; Krijgsveld J
    Expert Rev Proteomics; 2011 Feb; 8(1):29-42. PubMed ID: 21329426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomic analysis of human somatic cells, induced pluripotent stem cells, and embryonic stem cells.
    Kim SY; Kim MJ; Jung H; Kim WK; Kwon SO; Son MJ; Jang IS; Choi JS; Park SG; Park BC; Han YM; Lee SC; Cho YS; Bae KH
    Stem Cells Dev; 2012 May; 21(8):1272-86. PubMed ID: 21787230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential proteomics based on 18O labeling to determine the cyclin dependent kinase 9 interactome.
    Bezstarosti K; Ghamari A; Grosveld FG; Demmers JA
    J Proteome Res; 2010 Sep; 9(9):4464-75. PubMed ID: 20593818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar molecular signature of pluripotent stem cells.
    Pliss A; Kuzmin AN; Kachynski AV; Jiang H; Hu Z; Ren Y; Feng J; Prasad PN
    Anal Chem; 2013 Apr; 85(7):3545-52. PubMed ID: 23458184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global proteome analyses of SILAC-labeled skin cells.
    Sprenger A; Küttner V; Bruckner-Tuderman L; Dengjel J
    Methods Mol Biol; 2013; 961():179-91. PubMed ID: 23325643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media.
    Prowse AB; McQuade LR; Bryant KJ; Marcal H; Gray PP
    J Proteome Res; 2007 Sep; 6(9):3796-807. PubMed ID: 17655345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of differential proteomes of induced pluripotent stem cells by protein-based reprogramming of fibroblasts.
    Jin J; Kwon YW; Paek JS; Cho HJ; Yu J; Lee JY; Chu IS; Park IH; Park YB; Kim HS; Kim Y
    J Proteome Res; 2011 Mar; 10(3):977-89. PubMed ID: 21175196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
    Muñoz J; Heck AJ
    Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest developments in sample treatment for 18O-isotopic labeling for proteomics mass spectrometry-based approaches: a critical review.
    Capelo JL; Carreira RJ; Fernandes L; Lodeiro C; Santos HM; Simal-Gandara J
    Talanta; 2010 Feb; 80(4):1476-86. PubMed ID: 20082805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards.
    Ishihama Y; Sato T; Tabata T; Miyamoto N; Sagane K; Nagasu T; Oda Y
    Nat Biotechnol; 2005 May; 23(5):617-21. PubMed ID: 15834404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypsin immobilization on hairy polymer chains hybrid magnetic nanoparticles for ultra fast, highly efficient proteome digestion, facile 18O labeling and absolute protein quantification.
    Qin W; Song Z; Fan C; Zhang W; Cai Y; Zhang Y; Qian X
    Anal Chem; 2012 Apr; 84(7):3138-44. PubMed ID: 22413971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
    Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
    Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.